Free Trial

This company has been marked as potentially delisted and may not be actively trading.

IMARA (IMRA) Competitors

IMARA logo

IMRA vs. MOR, GMTX, CALT, ZYME, CMRX, CDMO, MENS, SBTX, MBX, and RVNC

Should you be buying IMARA stock or one of its competitors? The main competitors of IMARA include MorphoSys (MOR), Gemini Therapeutics (GMTX), Calliditas Therapeutics AB (publ) (CALT), Zymeworks (ZYME), Chimerix (CMRX), Avid Bioservices (CDMO), Jyong Biotech (MENS), Silverback Therapeutics (SBTX), MBX Biosciences (MBX), and Revance Therapeutics (RVNC).

IMARA vs. Its Competitors

MorphoSys (NASDAQ:MOR) and IMARA (NASDAQ:IMRA) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, media sentiment, dividends, profitability, valuation, earnings, risk and institutional ownership.

MorphoSys has a beta of 1.2, meaning that its share price is 20% more volatile than the S&P 500. Comparatively, IMARA has a beta of 1.09, meaning that its share price is 9% more volatile than the S&P 500.

18.4% of MorphoSys shares are owned by institutional investors. Comparatively, 49.3% of IMARA shares are owned by institutional investors. 0.1% of MorphoSys shares are owned by insiders. Comparatively, 37.3% of IMARA shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

IMARA has lower revenue, but higher earnings than MorphoSys. MorphoSys is trading at a lower price-to-earnings ratio than IMARA, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
MorphoSys$238.28M11.99-$205.35M-$3.48-5.45
IMARAN/AN/A$1.49M$0.05991.35

In the previous week, MorphoSys and MorphoSys both had 1 articles in the media. IMARA's average media sentiment score of 0.00 beat MorphoSys' score of -0.71 indicating that IMARA is being referred to more favorably in the news media.

Company Overall Sentiment
MorphoSys Negative
IMARA Neutral

IMARA has a net margin of 0.00% compared to MorphoSys' net margin of -226.79%. IMARA's return on equity of 2.12% beat MorphoSys' return on equity.

Company Net Margins Return on Equity Return on Assets
MorphoSys-226.79% -694.31% -22.55%
IMARA N/A 2.12%2.00%

Summary

IMARA beats MorphoSys on 9 of the 11 factors compared between the two stocks.

Get IMARA News Delivered to You Automatically

Sign up to receive the latest news and ratings for IMRA and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding IMRA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

IMRA vs. The Competition

MetricIMARAPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$1.30B$783.33M$5.46B$8.93B
Dividend YieldN/A4.84%5.24%4.04%
P/E Ratio991.551.3027.0720.17
Price / SalesN/A230.51381.5293.95
Price / Cash75.2423.4426.2128.59
Price / Book14.416.138.015.59
Net Income$1.49M-$27.85M$3.17B$248.41M

IMARA Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
IMRA
IMARA
N/A$49.57
-1.7%
N/AN/A$1.30BN/A991.5541
MOR
MorphoSys
N/A$18.96
flat
N/AN/A$2.86B$238.28M-5.45730
GMTX
Gemini Therapeutics
N/A$52.96
-2.8%
N/A+17.4%$2.29BN/A-52.9630
CALT
Calliditas Therapeutics AB (publ)
N/A$40.00
flat
N/AN/A$1.19B$1.60B-21.62180
ZYME
Zymeworks
2.0758 of 5 stars
$12.41
-1.1%
$21.00
+69.2%
+47.3%$863.45M$93.38M-8.27460
CMRX
Chimerix
0.6294 of 5 stars
$8.54
flat
$8.53
-0.1%
N/A$801.09M$212K-9.0990
CDMO
Avid Bioservices
0.693 of 5 stars
$12.50
+0.1%
$12.25
-2.0%
+68.4%$799.18M$139.91M-5.23320High Trading Volume
MENS
Jyong Biotech
N/A$8.48
-0.2%
N/AN/A$646.23MN/A0.0031Gap Up
SBTX
Silverback Therapeutics
N/A$17.45
-4.1%
N/A+81.5%$629.21MN/A-7.2183High Trading Volume
MBX
MBX Biosciences
3.0826 of 5 stars
$11.61
+1.8%
$37.50
+223.0%
N/A$388.05MN/A0.0036Positive News
RVNC
Revance Therapeutics
2.765 of 5 stars
$3.65
flat
$8.45
+131.5%
N/A$381.02M$234.04M-1.89500

Related Companies and Tools


This page (NASDAQ:IMRA) was last updated on 7/8/2025 by MarketBeat.com Staff
From Our Partners